118 related articles for article (PubMed ID: 26424162)
1. Design, synthesis and antiviral evaluation of 2'-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor.
Sizun G; Pierra C; Peyronnet J; Badaroux E; Rabeson C; Benzaria-Prad S; Surleraux D; Loi AG; Musiu C; Liuzzi M; Seifer M; Standring D; Sommadossi JP; Gosselin G
Future Med Chem; 2015; 7(13):1675-700. PubMed ID: 26424162
[TBL] [Abstract][Full Text] [Related]
2. The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors.
Alexandre FR; Badaroux E; Bilello JP; Bot S; Bouisset T; Brandt G; Cappelle S; Chapron C; Chaves D; Convard T; Counor C; Da Costa D; Dukhan D; Gay M; Gosselin G; Griffon JF; Gupta K; Hernandez-Santiago B; La Colla M; Lioure MP; Milhau J; Paparin JL; Peyronnet J; Parsy C; Pierra Rouvière C; Rahali H; Rahali R; Salanson A; Seifer M; Serra I; Standring D; Surleraux D; Dousson CB
Bioorg Med Chem Lett; 2017 Sep; 27(18):4323-4330. PubMed ID: 28835346
[TBL] [Abstract][Full Text] [Related]
3. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Brancale A; Zonta N; Chamberlain S; Vernachio J; Hutchins J; Hall A; Ames B; Gorovits E; Ganguly B; Kolykhalov A; Wang J; Muhammad J; Patti JM; Henson G
Bioorg Med Chem Lett; 2010 Aug; 20(16):4850-4. PubMed ID: 20637609
[TBL] [Abstract][Full Text] [Related]
5. Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.
Furman PA; Murakami E; Niu C; Lam AM; Espiritu C; Bansal S; Bao H; Tolstykh T; Micolochick Steuer H; Keilman M; Zennou V; Bourne N; Veselenak RL; Chang W; Ross BS; Du J; Otto MJ; Sofia MJ
Antiviral Res; 2011 Aug; 91(2):120-32. PubMed ID: 21600932
[TBL] [Abstract][Full Text] [Related]
6. Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects.
Zhou XJ; Pietropaolo K; Chen J; Khan S; Sullivan-Bólyai J; Mayers D
Antimicrob Agents Chemother; 2011 Jan; 55(1):76-81. PubMed ID: 21060109
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA.
Lam AM; Espiritu C; Bansal S; Micolochick Steuer HM; Zennou V; Otto MJ; Furman PA
J Virol; 2011 Dec; 85(23):12334-42. PubMed ID: 21957306
[TBL] [Abstract][Full Text] [Related]
8. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
9. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
McGuigan C; Perrone P; Madela K; Neyts J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW
J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149
[TBL] [Abstract][Full Text] [Related]
11. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.
Olsen DB; Eldrup AB; Bartholomew L; Bhat B; Bosserman MR; Ceccacci A; Colwell LF; Fay JF; Flores OA; Getty KL; Grobler JA; LaFemina RL; Markel EJ; Migliaccio G; Prhavc M; Stahlhut MW; Tomassini JE; MacCoss M; Hazuda DJ; Carroll SS
Antimicrob Agents Chemother; 2004 Oct; 48(10):3944-53. PubMed ID: 15388457
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
Good SS; Moussa A; Zhou XJ; Pietropaolo K; Sommadossi JP
PLoS One; 2020; 15(1):e0227104. PubMed ID: 31914458
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2'-C-methyl-6-O-methyl guanosine nucleoside and L-Alanine ester phosphoramidates.
Bourdin C; McGuigan C; Brancale A; Chamberlain S; Vernachio J; Hutchins J; Gorovits E; Kolykhalov A; Muhammad J; Patti J; Henson G; Bleiman B; Bryant KD; Ganguly B; Hunley D; Obikhod A; Walters CR; Wang J; Ramamurty CV; Battina SK; Srivinas Rao C
Bioorg Med Chem Lett; 2013 Apr; 23(7):2260-4. PubMed ID: 23453067
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
Oh CH; Kim E; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
[TBL] [Abstract][Full Text] [Related]
15. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
[TBL] [Abstract][Full Text] [Related]
16. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
[TBL] [Abstract][Full Text] [Related]
17. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents.
Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS
Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148
[TBL] [Abstract][Full Text] [Related]
19. Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infection.
Lalezari J; Asmuth D; Casiró A; Vargas H; Lawrence S; Dubuc-Patrick G; Chen J; McCarville J; Pietropaolo K; Zhou XJ; Sullivan-Bólyai J; Mayers D
Antimicrob Agents Chemother; 2012 Dec; 56(12):6372-8. PubMed ID: 23070151
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.
Yang S; K R J; Lim S; Choi TG; Kim JH; Akter S; Jang M; Ahn HJ; Kim HY; Windisch MP; Khadka DB; Zhao C; Jin Y; Kang I; Ha J; Oh BC; Kim M; Kim SS; Cho WJ
J Med Chem; 2015 Dec; 58(24):9546-61. PubMed ID: 26613291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
